Health
Novel Combinations Excite the R/R Hodgkin Lymphoma Treatment Landscape – Targeted Oncology
While the treatment of relapsed or refractory Hodgkin lymphoma has seen novel approaches in recent years improving outcomes for many patients, high-risk patients…
While the treatment of relapsed or refractory (R/R) Hodgkin lymphoma (HL) has seen novel approaches in recent years improving outcomes for many patients, high-risk patients develop progressive disease and have limited treatment options.1
Two studies presented during the 62nd American Society of Hematology Annual Meeting and Exposition explored new therapeutic strategies for this patient population. First, results from a phase 2 study (NCT04052997) suggest that camidanlumab tesirine (ADCT-301) can…
-
General17 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News23 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News21 hours agoPalestine protesters forced into last-minute reroute
-
Business21 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?